Lexaria Bioscience Corp. (LEXX) vs Liminatus Pharma, Inc. Class A Common Stock (LIMN)
A side-by-side comparison of Lexaria Bioscience Corp. and Liminatus Pharma, Inc. Class A Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LEXX
Lexaria Bioscience Corp.
$2.90HealthcareDelayed quote: Oct 6, 2026, 11:56 AM EDT
LIMN
Liminatus Pharma, Inc. Class A Common Stock
$3.85HealthcareDelayed quote: Oct 6, 2026, 11:44 AM EDT
Total return — LEXX vs LIMN
growth of $100 · dividends reinvested · last 1yLEXX -86.3% (-86.3%/yr)LIMN -98.4% (-98.4%/yr)LEXX compounded faster over this window
Log scale — wide-divergence pair
LEXX LIMN
LEXX vs LIMN: by the numbers
- •LIMN is the larger company ($5M vs $5M market cap).
- •Both run net losses; LIMN's is the smaller (0.00% vs -3985.58% net margin).
Metrics side by side
Valuation
| Metric | LEXX | LIMN |
|---|---|---|
| P/S ratio | 24.70 | N/A |
| P/B ratio | 1.01 | 17.20 |
Profitability
| Metric | LEXX | LIMN |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -1683.01% | 0.00% |
| Net margin | -3985.58% | 0.00% |
| ROE | -163.18% | -4165.92% |
| ROIC | -175.26% | -225.12% |
Growth (annualized)
| Metric | LEXX | LIMN |
|---|---|---|
| Revenue CAGR (5Y) | 12.92% | N/A |
| Total return CAGR (5Y) | -50.86% | N/A |
Go deeper
Dig into the metrics
Lexaria Bioscience ROELiminatus Pharma, Inc. Class A Common Stock ROELexaria Bioscience operating marginLiminatus Pharma, Inc. Class A Common Stock operating marginLexaria Bioscience revenue growthLiminatus Pharma, Inc. Class A Common Stock revenue growthLexaria Bioscience free cash flowLiminatus Pharma, Inc. Class A Common Stock free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.